IGC Pharma (IGC)
NYSE MKT:IGC
Holding IGC?
Track your performance easily

IGC Pharma (IGC) Financial Statements

877 Followers

IGC Pharma Financial Overview

IGC Pharma's market cap is currently ―. The company's EPS TTM is $-0.209; its P/E ratio is -1.83; IGC Pharma is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Dec 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 272.00K$ 204.00K$ 555.00K$ 165.00K$ 332.00K
Gross Profit$ 163.00K$ 133.00K$ 255.00K$ 63.00K$ 102.00K
EBIT$ -2.38M$ -3.00M$ -2.07M$ -4.70M$ -2.25M
EBITDA$ -2.21M$ -2.84M$ -1.92M$ -4.54M$ -2.08M
Net Income Common Stockholders$ -2.38M$ -5.59M$ -2.08M$ -4.07M$ -2.25M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.82M$ 1.38M$ 1.95M$ 3.35M$ 5.03M
Total Assets$ 10.59M$ 11.26M$ 15.67M$ 17.18M$ 20.07M
Total Debt$ 205.00K$ 253.00K$ 319.00K$ 348.00K$ 382.00K
Net Debt$ -1.62M$ -1.13M$ -1.63M$ -3.01M$ -4.65M
Total Liabilities$ 2.71M$ 2.21M$ 2.47M$ 2.27M$ 1.75M
Stockholders Equity$ 7.88M$ 9.05M$ 13.20M$ 14.91M$ 18.32M
Cash Flow-
Free Cash Flow$ -1.88M$ -1.67M$ -1.47M$ -1.69M$ -1.77M
Operating Cash Flow$ -1.75M$ -1.59M$ -1.47M$ -1.52M$ -1.65M
Investing Cash Flow$ -131.00K$ -61.00K$ -5.00K$ -242.00K$ -17.00K
Financing Cash Flow$ 2.51M$ -1.00K$ -1.00K$ -1.00K-
Currency in USD

IGC Pharma Earnings and Revenue History

IGC Pharma Debt to Assets

IGC Pharma Cash Flow

IGC Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis